Leerink Partners analyst, Geoffrey Porges, reiterated his Market Perform rating on shares of Biogen (NASDAQ: BIIB) following Biogen’s disclosure of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE